DaVita Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:DaVita Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4441
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

DaVita Inc. – Strategy, SWOT and Corporate Finance Report
Summary

DaVita Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

DaVita Inc. (DaVita or ‘the company’), formerly known as DaVita Healthcare Partners, is one of the leading providers of dialysis services in the US for patients suffering from chronic kidney failure and end stage renal disease (ESRD). It offers hemodialysis, peritoneal dialysis and kidney transplantation related services and operates through a network of outpatient dialysis centers in hospitals and related laboratory services. DaVita is headquartered in Denver, Colorado, the US.

Scope

- Detailed information on DaVita Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting DaVita Inc. in the form of a SWOT analysis
- An in-depth view of the business model of DaVita Inc. including a breakdown and examination of key business segments
- Intelligence on DaVita Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about DaVita Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of DaVita Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess DaVita Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on DaVita Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
DaVita Inc.: Company Overview 9
DaVita Inc.: Overview and Key Facts 9
DaVita Inc.: Overview 9
DaVita Inc.: Key Facts 9
DaVita Inc.: Key Employees 11
DaVita Inc.: Key Employee Biographies 12
DaVita Inc.: Major Products and Services 18
DaVita Inc.: Company History 19
DaVita Inc.: Management Statement 22
DaVita Inc.: Locations and Subsidiaries 23
DaVita Inc.: Key Competitors 25
DaVita Inc.: Company Analysis 26
DaVita Inc.: Business Description 26
DaVita Inc.: SWOT Analysis 27
DaVita Inc.: SWOT Overview 27
DaVita Inc.: Strengths 27
DaVita Inc.: Weaknesses 28
DaVita Inc.: Opportunities 28
DaVita Inc.: Threats 29
DaVita Inc.: Corporate Financial Deals Activity 31
DaVita Inc.: Financial Deals Overview 31
DaVita Inc.: Targets and Partners 33
DaVita Inc.: Top Deals 2014 – 2018YTD* 34
DaVita Inc.: Mergers and Acquisitions 35
DaVita Inc.: Partnership 36
DaVita Inc.: Divestments 37
DaVita Inc.: Recent Developments 38
DaVita Inc.: News and Events Summary 38
DaVita Inc.: Contracts 41
DaVita Inc.: Corporate Governance 42
DaVita Inc.: Financial Performance 43
DaVita Inc.: Market Developments 43
DaVita Inc.: Regulatory and Legal Events 44
Appendix 46
Contact Us 46
Methodology 46
About MarketLine 47

List of Tables
Table 1: DaVita Inc.: Key Facts
Table 2: DaVita Inc.: Key Employees
Table 3: DaVita Inc.: Locations and Subsidiaries
Table 4: DaVita Inc.: Key Competitors
Table 5: DaVita Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: DaVita Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: DaVita Inc.: Targets and Partners
Table 8: DaVita Inc.: Top Deals 2014 - 2018YTD*
Table 9: DaVita Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: DaVita Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 11: DaVita Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 12: DaVita Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 13: DaVita Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 14: DaVita Inc.: Divestments by Geography (2014 - YTD*2018)
Table 15: DaVita Inc.: News and Events Summary
Table 16: DaVita Inc.: Contracts
Table 17: DaVita Inc.: Corporate Governance
Table 18: DaVita Inc.: Financial Performance
Table 19: DaVita Inc.: Market Developments
Table 20: DaVita Inc.: Regulatory and Legal Events

List of Figures
Figure 1: DaVita Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: DaVita Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: DaVita Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: DaVita Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: DaVita Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 6: DaVita Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 7: DaVita Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 8: DaVita Inc.: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[DaVita Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rafako SA (RFK):企業の財務・戦略的SWOT分析
    Rafako SA (RFK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Humana Inc (HUM)-医療機器分野:企業M&A・提携分析
    Summary Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and …
  • Red Hat Inc:企業の戦略的SWOT分析
    Red Hat Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SPAR Osterreichische Warenhandels AG:企業の戦略的SWOT分析
    SPAR Osterreichische Warenhandels AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Nipro Corp (8086):医療機器:M&Aディール及び事業提携情報
    Summary Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary …
  • Imagion Biosystems Inc:製品パイプライン分析
    Summary Imagion Biosystems Inc (Imagion Biosystems), formerly Senior Scientific LLC, a subsidiary of Manhattan Scientifics Inc, is a biomedical equipment provider that offers nanomagnetic particle detection systems. The company offers nanomagnetic relaxometry method for cancer detection and precisio …
  • Emirates National Oil Co Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Emirates National Oil Co Ltd (ENOC) is an oil and gas company that offers downstream and upstream activities. The company’s products include liquid petroleum gas, aviation fuel, lubricants, chemicals, and LPG containers. It offers services such as trading, supplying, processing, marketing, t …
  • Orlando Utilities Commission:企業の戦略的SWOT分析
    Orlando Utilities Commission - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Westfalen Weser Netz GmbH:企業の戦略的SWOT分析
    Westfalen Weser Netz GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Interfor Corp:企業の戦略・SWOT・財務情報
    Interfor Corp - Strategy, SWOT and Corporate Finance Report Summary Interfor Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Zocere Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Zocere Inc (Zocere), formerly Tyrosine Pharmaceuticals Inc is a biotechnology company that develops novel therapeutics for neurological diseases. The company offers services to support the pharmaceutical and biotechnology fields developing stroke-related diagnostics and treatments. Its drugs …
  • Symbiotec Pharmalab Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Symbiotec Pharmalab Ltd (Symbiotec) is a medical laboratory that manufactures active pharmaceutical ingredients. The laboratory develops, produces and markets research-based cortico steroids and steroid-hormone APIs. Its cortico-steroids APIs include clobetasol propionate, betamethasone dipr …
  • Verseon Corp (VSN):企業の財務・戦略的SWOT分析
    Summary Verseon Corp (Verseon) is a pharmaceutical company that develops novel therapeutics. The company develops drug programs in the therapeutic areas of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology. Its anticoagulation program develops oral anticoagulants for cardi …
  • Recipharm AB (RECI B):企業の財務・戦略的SWOT分析
    Recipharm AB (RECI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Temple Hotels Inc.:企業の戦略・SWOT・財務分析
    Temple Hotels Inc. - Strategy, SWOT and Corporate Finance Report Summary Temple Hotels Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Goa Shipyard Ltd:企業の戦略・SWOT・財務分析
    Goa Shipyard Ltd - Strategy, SWOT and Corporate Finance Report Summary Goa Shipyard Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Avanti Energy Inc (AVN):企業の財務・戦略的SWOT分析
    Summary Avanti Energy Inc (Avanti Energy), formerly known as Overlord Capital Ltd is an oil and gas exploration and production company. The company acquires, explores, and develops gas reserves in Central Italy. It re-develops the existing oil and gas reserves. Avanti Energy owns the Colle Santo gas …
  • Frito-Lay North America, Inc.:企業の戦略・SWOT・財務情報
    Frito-Lay North America, Inc. - Strategy, SWOT and Corporate Finance Report Summary Frito-Lay North America, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Aviragen Therapeutics Inc (AVIR)-製薬・医療分野:企業M&A・提携分析
    Summary Aviragen Therapeutics Inc (Aviragen) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases. It has four product candidates in clinical development which address viral infections, namely, vapendavir, ora …
  • ABM Industries Incorporated (ABM):企業の財務・戦略的SWOT分析
    ABM Industries Incorporated (ABM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆